Jpmorgan Chase & Co »

Perspective Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Perspective Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $200k 20k 9.97

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management
Citadel Advisors
Affinity Asset Advisors

View all funds holding Perspective Therapeutics